Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins
- PMID: 36772961
- DOI: 10.1111/ans.18320
Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins
Abstract
Backgrounds: Myxofibrosarcomas (MFS) are malignant soft tissue sarcomas with an infiltrative growth pattern and propensity for local recurrence(LR).We aimed to assess our management of MFS and make recommendations about the role of a multidisciplinary team approach and margin widths.
Methods: Fifty-seven patients were identified with MFS treated at a single sarcoma centre between 1998 and 2020. Patients were stratified based on whether they presented for a planned resection (59.6%) or after an unplanned resection (40.4%) performed at a non-specialized facility. All patients underwent radiotherapy before definitive surgery.
Results: 73.7% underwent a combined onco-plastic approach. The 5 year LRFS rate was 78.2% (84.4%, planned, versus 70.1%, unplanned, P = 0.194) and found comparable oncological outcomes between the planned and unplanned groups for the 5 year metastasis free survival (74.5% versus 86.1%, P = 0.257), disease free survival (70.1% versus 72.4%, P = 0.677), and Overall Survival (64.5% versus 75.9%, P = 0.950). Margin width ≥ 2 cm was obtained in 84.2% of cases and improved local control (HR = 0.22; 95% CI 0.06-0.81; P = 0.023), metastasis (HR = 0.24; 95% CI 0.07-0.80; P = 0.019) and mortality rates (HR = 0.23; 95% CI 0.09, 0.61; P = 0.003) compared to <2 cm. Margin width > 3 cm did not further affect oncological outcomes.
Conclusion: Our study shows that a multidisciplinary team approach allows the achievement of low local recurrence rate and good oncological outcomes of myxofibrosarcomas, regardless of presentation status. We recommend a minimum of 2 cm margin width.
Keywords: Margin width; Multidisciplinary; Myxofibrosarcoma; oncological outcomes; sarcoma.
© 2023 The Authors. ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.
References
-
- Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg. Oncol. Clin. N. Am. 2016; 25: 775-88.
-
- Waters B, Panicek DM, Lefkowitz RA et al. Low-grade myxofibrosarcoma: CT and MRI patterns in recurrent disease. Am. J. Roentgenol. 2007; 188: W193-W8.
-
- Sanfilippo R, Miceli R, Grosso F et al. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann. Surg. Oncol. 2011; 18: 720-5.
-
- Yoo HJ, Hong SH, Kang Y et al. MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. Eur. Radiol. 2014; 24: 1749-57.
-
- Kaya M, Wada T, Nagoya S et al. MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skeletal Radiol. 2008; 37: 1085-90.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
